Predictors and patterns of recurrence after definitive chemoradiation for anal cancer

	Tweet

PURPOSE: To evaluate patterns of locoregional failure, and predictors of recurrence and survival in patients treated with chemoradiation for anal cancer.

METHODS AND MATERIALS: Between September 1992 and August 2004, 167 patients with nonmetastatic squamous cell anal carcinoma were treated with definitive chemoradiation. The median dose of radiotherapy was 5500 cGy. Concurrent chemotherapy was given with 5-fluorouracil and cisplatin in 117 patients, 5-fluorouracil and mitomycin C in 24 patients, and other regimens in 26 patients.

RESULTS: The estimated 3-year rates of locoregional control, distant control, disease-free survival, and overall survival were 81%, 88%, 67%, and 84%, respectively. Multivariate analysis showed that higher T stage and N stage independently predicted for a higher rate of locoregional failure; higher N stage and basaloid subtype independently predicted for a higher rate of distant metastasis; and higher N stage and positive human immunodeficiency virus status independently predicted for a lower rate of overall survival.

Among the patients who had locoregional failure, 18 (75%) had failure involving the anus or rectum, 5 (21%) had other pelvic recurrences, and 1 (4%) had inguinal recurrence. The 5 pelvic recurrences all occurred in patients with the superior border of the radiotherapy field at the bottom of the sacroiliac joint.

CONCLUSIONS: Trials of more aggressive and innovative locoregional and systemic therapies are warranted in high-risk patients, based on their T and N stages. The majority of locoregional failures involve the anus and rectum, whereas inguinal recurrences occur rarely. Placing the superior border of the radiotherapy field at L5/S1 could potentially reduce pelvic recurrences.

Das P, Bhatia S, Eng C, Ajani JA, Skibber JM, Rodriguez-Bigas MA, Chang GJ, Bhosale P, Delclos ME, Krishnan S, Janjan NA, Crane CH.

Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA.

Int J Radiat Oncol Biol Phys. 2007 Jul 1;68(3):794-800. Epub 2007 Mar 26.

RELATED STORIES:
Vitamin B6 may reduce colon cancer risk in women   Aspirin’s ability to protect against colorectal cancer may depend on inflammatory pathways   Soy May Reduce the Risk of Colorectal Cancer   Metabolic syndrome ups colorectal cancer risk   Women on bone drugs have less colon cancer: study   Other Illnesses, Body Weight Do Not Explain Racial Disparities in Colon Cancer Survival   Major Advance in Search for Genes Associated with Colon Cancer   Chemicals in curry and onions may help prevent colon cancer   Race affects regional colorectal cancer screening disparities   Long-term aspirin lowers colon cancer risk   Celecoxib May Help Prevent Colorectal Cancer In High Risk Patients   Calcium Associated With Lower Risk of Cancer in Women   Targeted Therapies Showing Great Promise Against Colorectal Cancer   A new indicator of poor prognosis in node-negative colorectal cancer patients   US cancer deaths down but far too few Americans screened for colon cancer   Stool Testing Novel Technique for Detecting Colon Cancer   Aspirin reduces risk of colon polyps recurring   Following lifestyle tips could prevent almost a quarter of bowel cancer cases   Lifestyle Changes Would Lead to Sharp Drop in Colorectal Cancers   The cellular root of colorectal cancers?   New report says racial gap growing in colorectal cancer   LOH analysis on 4q in sporadic colorectal carcinoma

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]